Elevar Therapeutics, Inc., a majority-owned subsidiary of HLB Co., Ltd. and a fully integrated biopharmaceutical company dedicated to elevating treatment experiences and outcomes for patients who have ...

Elevar on Jan. 23, 2026, submitted the NDA for rivoceranib, while Hengrui Pharma submitted a biologics license application (BLA) for camrelizumab. The FDA will review the applications under an ...

Where do markets go in 2026? As in 2025, implied expectations embedded in derivatives-market data have already offered an ...

Bamuturaki is partly responsible for her own downfall because some of the actions and decisions she took were allegedly done ...

On January 16, 2026, the Securities and Exchange Commission (SEC) instituted settled cease‑and‑desist proceedings against Ankit Mahadevia ...

The dispute concerned whether transfer through a release deed amounted to a taxable sale and justified loss claims. The Tribunal remanded the matter, directing verification of books to examine the ...

China’s agritech industry is central to modernizing the sector and bolstering food security, creating new opportunities for investors.

Already imprisoned at Adiala jail, the duo have been sentenced to total of 17 years in prison on multiple offences under Peca.

As K League 2 prepares to welcome three new clubs—bringing the total number to a record-high 17—we look at how other ...

The Delhi High Court on Thursday dismissed a defamation case filed by IRS officer Sameer Wankhede against Aryan ...

Analysis of liquidity, regionalization, and the new asset allocation strategy. Key themes: commodities, AI infrastructure, and defense.

There is no better time of the year to visit Gujarat’s Rann of Kutch than in winter, with the surrounding places offering a ...